Vascular Biogenics Ltd (NASDAQ:VBLT)
| 1.35 Delayed Data As of Aug 05 |  +0.04 / +3.08%Today’s Change | 0.90 Today|||52-Week Range 1.64 | +12.50% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $62.7M |
Company Description
Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of first-in-class treatments for cancer. Its programs include cancer, inflammation, and VB-600 which are focused on treating tumors, ovarian cancer, and chronic immune-related indications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.
Contact Information
Vascular Biogenics Ltd. 8 HaSatat Street Modi’in Jerusalem 7178106 |
Employees
Shareholders
| Other institutional | 6.52% |
| Individual stakeholders | 10.14% |
| Mutual fund holders | 0.79% |
Top Executives
| Dror Harats | Chief Executive Officer & Director |
| Eyal Breitbart | Vice President-Research & Operations |
| Erez Feige | Vice President-Business Operations |
| Amos Ron | Chief Financial Officer & Secretary |
| Tami Rachmilewitz | Vice President-Clinical Development |
